Teizo Asano

1.4k citations
83 papers · 877 · h-index 18

Impact in

  • Oncology top 5%
    • Chemokine receptors and signaling
    • HER2/EGFR in Cancer Research
  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immune Cell Function and Interaction

Papers in

    • Chemokine receptors and signaling 22
    • Lymphatic System and Diseases 14
    • HER2/EGFR in Cancer Research 14
    • Immunotherapy and Immune Responses 26
    • T-cell and B-cell Immunology 18
    • Immune Cell Function and Interaction 14

Teizo Asano

83 papers receiving 877 citations

Peers

Teizo Asano
Comparison fields: 5 of 44
  • Oncology 601
  • Immunology 455
  • Physiology 64
  • Radiology, Nuclear Medicine and Imaging 285
  • Cell Biology 110
Replace Sheila Spada with:
Sheila Spada United States
Mieke Versluis Netherlands
Martina Fatho Germany
Michele Rhodes United States
Mustapha Faroudi France
Yannick Guilloux France
Casey W. Shuptrine United States
Angela Stoddart United States
Andrew Scott United States
Vidyalakshmi Chandramohan United States
Teizo Asano relative to Sheila Spada United States Sheila Spada's profile →
Citations per field
00.5×7.0×
Sheila Spada · 1×
Citations per year

Countries citing papers authored by Teizo Asano

Since Specialization
Citations

This map shows the geographic impact of Teizo Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teizo Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teizo Asano more than expected).

Fields of papers citing papers by Teizo Asano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teizo Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teizo Asano. The network helps show where Teizo Asano may publish in the future.

Co-authors

The 25 scholars most cited alongside Teizo Asano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Teizo Asano Line = papers co-authored together Teizo Asano links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.

#Work
1 202137
2 202137
3 202132
4 202128
5 202027
6 202125
7 202023
8 202122
9 202122
10 202121
11 202321
12 202020
13 202120
14 202020
15 202119
16 202019
17 202119
18 202217
19 202017
20 202316

About Teizo Asano

Teizo Asano is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Surgery, having authored 83 papers that have together received 877 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (36 papers), Immunotherapy and Immune Responses (26 papers), Glycosylation and Glycoproteins Research (25 papers), Chemokine receptors and signaling (22 papers), T-cell and B-cell Immunology (18 papers), Lymphatic System and Diseases (14 papers), Immune Cell Function and Interaction (14 papers) and HER2/EGFR in Cancer Research (14 papers). The work is most often cited by research in Oncology (601 citations), Immunology (455 citations), Physiology (64 citations), Radiology, Nuclear Medicine and Imaging (285 citations) and Cell Biology (110 citations). Teizo Asano has collaborated with scholars based in Japan. Frequent co-authors include Yukinari Kato, Mika K. Kaneko, Junko Takei, Hiroyuki Suzuki, Masato Sano, Hideki Hosono, Takuro Nakamura, Tomohiro Tanaka, Miyuki Yanaka and Ren Nanamiya. Their work appears in journals such as Oncology Reports, Antibodies, International Journal of Molecular Medicine, International Journal of Molecular Sciences and Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact